Kimberly Michael B, Hoehn K Sarah, Feudtner Chris, Nelson Robert M, Schreiner Mark
Pediatric Generalist Research Group, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Pediatrics. 2006 May;117(5):1706-11. doi: 10.1542/peds.2005-1233.
To systematically compare standards for compensation and child participant assent in informed permission, assent, and consent forms (IP-A-CFs) approved by 55 local institutional review boards (IRBs) reviewing 3 standardized multicenter research protocols.
Sixty-nine principal investigators participating in any of 3 national, multicenter clinical trials submitted standardized research protocols for their trials to their local IRBs for approval. Copies of the subsequently IRB-approved IP-A-CFs were then forwarded to an academic clinical research organization. This collection of IRB-approved forms allowed for a quasiexperimental retrospective evaluation of the variation in informed permission, assent, and consent standards operationalized by the local IRBs.
Standards for compensation and child participant assent varied substantially across 69 IRB-approved IP-A-CFs. Among the 48 IP-A-CFs offering compensation, monetary compensation was offered by 33 as reimbursement for travel, parking, or food expenses, whereas monetary or material compensation was offered by 22 for subject inconvenience and by 13 for subject time. Compensation ranged widely within and across studies (study 1, $180-1425; study 2, $0-500; and study 3, $0-100). Regarding child participant assent, among the 57 IP-A-CFs that included a form of assent documentation, 33 included a line for assent on the informed permission or consent form, whereas 35 included a separate form written in simplified language. Of the IP-A-CFs that stipulated the documentation of assent, 31 specified > or =1 age ranges for obtaining assent. Informed permission or consent forms were addressed either to parents or child participants.
In response to identical clinical trial protocols, local IRBs generate IP-A-CFs that vary considerably regarding compensation and child participant assent.
系统比较55个当地机构审查委员会(IRB)批准的知情许可、同意和同意书(IP-A-CF)中关于补偿和儿童参与者同意的标准,这些委员会审查了3个标准化的多中心研究方案。
参与3项全国性多中心临床试验的69位主要研究者将其试验的标准化研究方案提交给当地IRB审批。随后,IRB批准的IP-A-CF副本被转发给一个学术临床研究组织。这组IRB批准的表格允许对当地IRB实施的知情许可、同意和同意标准的差异进行准实验性回顾性评估。
在69份IRB批准的IP-A-CF中,补偿和儿童参与者同意的标准差异很大。在提供补偿的48份IP-A-CF中,33份提供金钱补偿以报销差旅费、停车费或食品费用,22份提供金钱或物质补偿以弥补受试者不便,13份提供金钱或物质补偿以弥补受试者时间。不同研究内部和之间的补偿范围差异很大(研究1,180美元至1425美元;研究2,0美元至500美元;研究3,0美元至100美元)。关于儿童参与者同意,在57份包含某种同意文件形式的IP-A-CF中,33份在知情许可或同意书上包含同意栏,35份包含用简化语言编写的单独表格。在规定同意文件记录的IP-A-CF中,31份指定了≥1个获得同意的年龄范围。知情许可或同意书是写给父母或儿童参与者的。
针对相同的临床试验方案,当地IRB生成的IP-A-CF在补偿和儿童参与者同意方面差异很大。